darunavir has been researched along with rivaroxaban in 2 studies
| Studies (darunavir) | Trials (darunavir) | Recent Studies (post-2010) (darunavir) | Studies (rivaroxaban) | Trials (rivaroxaban) | Recent Studies (post-2010) (rivaroxaban) |
|---|---|---|---|---|---|
| 1,148 | 224 | 780 | 4,741 | 569 | 4,357 |
| Protein | Taxonomy | darunavir (IC50) | rivaroxaban (IC50) |
|---|---|---|---|
| Coagulation factor X | Homo sapiens (human) | 0.0038 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Battegay, M; Elzi, L; Lakatos, B; Marzolini, C; Stoeckle, M | 1 |
2 other study(ies) available for darunavir and rivaroxaban
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Gastrointestinal bleeding associated with rivaroxaban administration in a treated patient infected with human immunodeficiency virus.
Topics: Ankle Fractures; Anticoagulants; Darunavir; Drug Interactions; Gastrointestinal Hemorrhage; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Morpholines; Ritonavir; Rivaroxaban; Sulfonamides; Thiophenes | 2014 |